Quantum BioPharma is trading at $2.12 (-5.58%), with no clear company-specific catalyst identified. - Search results showed no company-specific announcement explaining the October 26 decline. - A summit item referred to a September 16 event and was announced September 15, so it is not a new catalyst for this session. - Major U.S. indices were modestly higher; the cause of the decline remains uncertain.